From: Therapeutic drug monitoring of meropenem and piperacilin administered in continuous infusion. preliminary data
antibiotic
Cases
ƒCss < 4MIC
ƒCss 4-10 MIC
ƒCss >10 IMC
Meropenem 2 g
14
6 (43%)
7 (50%)
1 (7%)
Piperacilin-tazobactam 16g
15
2 (13 %)
9 (60%)
4 (27%)
Piperacilin-tazobactam 24g
31
11 (35%)
16 (52%)
4 (13%)
Total
60
19 (32%)
32 (53%)
9 (15%)